Clinical Trial Search

Primary: Cardiac Index — 3.39; 3.42; 3.23 L/min/m2

Primary: To Evaluate the Incidence of the Pre-proendothelin SNP at Nucleotide 5665 — 10 participants

Primary: Transition Readiness Assessment Questionnaire (TRAQ) Score — 2.77; 2.95; 3.80; 3.92 units on a scale

Primary: Feasibility of Pacemaker Implant With Total Thoracoscopic Approach to Epicardial Pacing Lead — 100 percentage of particiapants

Primary: Left Ventricular Mass Index — 67; 60 g/m2 — p=0.27

Primary: Acetaminophen Serum Concentrations — 19; 17; 13; 13 mcg/mL

Primary: Comparison Between CASES and CONTROLS of the Occurrence of Specific Clinical Outcomes of Serious Infection, Serious Arrhythmia and/or Death — 303; 349 participants

Primary: Mean Difference in Stroke Volume Between CMR and SMIC — 1.7 ml — p=0.47

Primary: Coronary Flow Reserve (CFR) — 1.77 ratio: peak to baseline CFV

Primary: Number of Incidence of Treatment Related Major Adverse Cardiac Events — 1; 0; 6 Events

Primary: Blood 25 Hydroxyvitamin D (25OHD) Concentrations — 34.8; 52.0 nmol/L

Primary: Number of Participants With Major Cardiac Adverse Events Related to Transcoronary Infusion of CDCs. — 1 Participants

Primary: Maximum Decline in Measured Cardiac Output — 0.68; 0.29 L/min/m2

Primary: Oxygenation Response — 4.2; 2.6 Change in Oxygenation Index

Primary: BNP Levels — 16.3; 42.4; 384.3 pg/ml

Primary: Feasibility Evaluation and Major Cardiac Adverse Events Related to Transcoronary Infusion of Cardiac Progenitor Cells — 0; 0 participants

Primary: Changes in Hemodynamic Variables Recorded During Administration of Sevoflurane + Dexmedetomidine. — -0.14; -0.16; -0.21; 0.15 percentage of change from baseline — p=0.05

Primary: Moderate to Vigorous Physical Activity (MVPA) — -1.9; 3.4 average minutes per day — p=0.24

Primary: Composite Image Quality Score Among 7 Anatomical Structures. — 3.9; 2.7 score on a scale

Primary: Number of Subjects Reporting Adverse Events Through Study Day 150 — 575; 566 participants

Primary: Improvement in Left Ventricular Ejection Fraction — 42.1; 37.6 Percentage — p=0.267

Primary: Change in KAH Score for Children — 7.66; 3.76 units on a scale — p=<.001

Primary: (PAI-1) Plasminogen Activator Inhibitor -1 Antigen — 4.59; 3.78; 13.59; 17.8 ng/ml — p=0.03

Primary: S-creatinine — 23.9; 25.9; 33.7; 34.2 μmol/L — p=0.45

Primary: Mean Arterial Lactate Level — 1.4; 1.4 mmol/L

Primary: Average Left-Ventricular Wall Thickness-Dimension Ratio Z-score (LVWT/Dz) — -0.1372; -0.0893; -0.2167; 0.3215 z-score — p=0.15

Primary: Time to First Post-operative Negative 24 Hour Fluid Balance — 2.7; 2.67 Days

Primary: Number of Participants With Acute Kidney Injury — 18; 57 Participants

Primary: Severity of Adhesions at the Retrosternal Site — 0; 31.3; 0; 37.5 percentage of participants

Primary: Composite of Adjudicated Major or Clinically Relevant Non-Major (CRNM) Bleeding Events — 1; 3 Participants